Live tape
Top 8, mentions 7d17,533MSFT3,305 mentions▲ +0.08GOOGL2,684 mentions▲ +0.05AAPL2,292 mentions▲ +0.07META2,228 mentions▲ +0.04SPCX1,993 mentions▲ +0.06SNDK1,851 mentions▲ +0.06NVDA1,752 mentions▲ +0.07QQQ1,428 mentions▲ +0.04

Equity · Healthcare

BLCO

Bausch + Lomb Corporation · NYSE

$16.61 +2.06% 1D Finazon · prior-day close · Jul 28, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of BLCO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 63 sessions over that window: $16.00 on 1 May 2026 through $16.61 on 28 July 2026. Finazon · prior-day close.

Market cap $5.9B
52-week range $13.51 – $18.60
Avg volume 93.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

BLCO insider trades

SEC Form 4 · last 90 days · newest reported trade 12 Jun 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 15

Showing the 12 most recent of 15 filings in this window. The figures above count all of them.

Compensation mechanics (12 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Jun 2026 Bonnefoy Luc President, Surgical Tax withheld 1,008 $15K
26 May 2026 Alfonso Eduardo Director Award 15,842 $250K
26 May 2026 Bernier Nathalie D. Director Award 15,842 $250K
26 May 2026 COLLIS STEVEN H Director Award 15,842 $250K
26 May 2026 KAVANAGH SARAH B Director Award 15,842 $250K
26 May 2026 Ling Karen Director Award 15,842 $250K
26 May 2026 Paulson John Director Award 15,842 $250K
26 May 2026 ROBERTSON RUSSEL C Director Award 15,842 $250K
26 May 2026 Ross Thomas W. Sr. Director Award 15,842 $250K
26 May 2026 VON ESCHENBACH ANDREW C. Director Award 15,842 $250K
22 May 2026 SAUNDERS BRENT L Chairman of the Board and CEO Tax withheld 2,886 $46K
05 May 2026 Bonnefoy Luc President, Surgical Tax withheld 11,970 $192K

BLCO reported financials

SEC EDGAR XBRL

BLCO reported revenue of $5.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$360.0M.

Figure Reported Period
Revenue $5.1B 31 Dec 2025 fiscal year
Net income −$360.0M 31 Dec 2025 fiscal year
Diluted EPS −$1.02 31 Dec 2025 fiscal year
Total assets $13.9B 30 Jun 2026 at period end
Total equity $6.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BLCO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.04 $1.39B
31 Mar 2026 Q1 2026 $-0.20 $1.24B
31 Dec 2025 FY 2025 $-1.02 $5.10B
30 Sep 2025 Q3 2025 $-0.08 $1.28B

Reported figures & scheduled dates · SEC EDGAR filings

BLCO institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a BLCO position for the quarter ended 31 Mar 2026 — a combined $220.0M; the latest of those filings landed 20 May 2026.

Fund Action Shares Value
Carl Icahn Held (±25%) 3,500,000 $55.7M
Oaktree Capital Management Held (±25%) 3,382,739 $53.8M
D. E. Shaw & Co. Held (±25%) +10.7% shares 3,151,167 $50.1M
Glenview Capital Management Held (±25%) +15.5% shares 1,910,496 $30.4M
Citadel Advisors Held (±25%) −22.6% shares 705,221 $11.2M
Tudor Investment Corp Added +312.5% shares 376,446 $6.0M
Millennium Management Added +278.8% shares 303,163 $4.8M
Point72 Asset Management Added +1,947.7% shares 283,138 $4.5M
Balyasny Asset Management Added +43.3% shares 133,262 $2.1M
Marshall Wace New position 63,871 $1.0M

Source: SEC EDGAR 13F filings

BLCO fails-to-deliver

SEC CNS data

On 22 Jun 2026, 8,088 shares of BLCO failed to deliver (about $120K).

Settlement date Shares failed Notional % of shares out
22 Jun 2026 8,088 $120K 0.002%

Source: SEC fails-to-deliver (CNS) data